Lataa...
Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells
The use of liposomes as drug carriers improves the therapeutic efficacy of anti-cancer drugs, while at the same time reducing side effects. Hyaluronic acid (HA) is recognized by the CD44 receptor, which is over-expressed in many cancer cells. In this study, we developed HA-modified liposomes encapsu...
Tallennettuna:
| Julkaisussa: | J Cell Physiol |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7384933/ https://ncbi.nlm.nih.gov/pubmed/31989649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.29576 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|